Table 1: Results of the preoperative blood tests.
|
Peripheral blood |
Biochemistry |
Serology |
|||
|
White
blood cells |
5.5×103/μL |
C-reactive
protein |
0.19
mg/dL |
HBs-Ag |
(-) |
|
Neutrophils |
63.80% |
Total
protein |
7.0
g/dL |
HCV-Ab |
(-) |
|
Eosinophils |
1.70% |
Albumin |
3.6
g/dL |
HIV-Ab |
(-) |
|
Basophils |
0.80% |
Total
bilirubin |
0.99
mg/dL |
Tumor markers |
|
|
Monocytes |
7.60% |
Alkaline
phosphatase |
181
IU/L |
PIVKA-Ⅱ |
26
AU/mL |
|
Lymphocytes |
26.10% |
γ-Glutamyl
transpeptidase |
32
IU/L |
CEA |
4.4
ng/mL |
|
Red
blood cells |
458×104/μL |
Aspartate
aminotransferase |
19
IU/L |
CA19-9 |
107
U/mL |
|
MCV |
95.3
fL |
Alanine
aminotransferase |
11
IU/L |
AFP |
1
ng/mL |
|
MCH |
30.9
pg |
Lactate
dehydrogenase |
190
IU/L |
sIL-2R |
816
U/mL |
|
MCHC |
32.40% |
Blood-urea-nitrogen |
25
mg/dL |
||
|
Haemoglobin |
14.1
g/dL |
Creatinine |
1.79
mg/dL |
||
|
Hematocrit |
43.70% |
Uric
acid |
mg/dL |
||
|
Platelet
count |
1.73×104/μL |
Na |
139
mEq/L |
||
|
Coagulation |
K |
5.3
mEq/L |
|||
|
PT-INR |
1.18 |
Cl |
106
mEq/L |
||
|
APTT |
32.8
seconds |
Ferritin |
193.5
ng/mL |
AFP:
alpha-fetoprotein; APTT: activated partial thromboplastin time; CA19-9:
carbohydrate antigen 19-9; CEA: carcinoembryonic antigen; HBs Ag: hepatitis B
surface antigen; HCV-Ab: hepatitis C virus antibody; HIV-Ab: human
immunodeficiency virus antibody; MCV: mean corpuscular volume; MCH: mean
corpuscular haemoglobin; MCHC: mean corpuscular haemoglobin concentration;
PIVKA-II: protein induced by vitamin K absence-II; PT-INR: prothrombin
time-international normalized ratio; sIL-2R: soluble interleukin-2 receptor.